NCT03804021View on ClinicalTrials.gov

Long-Term Follow-up Study of ADVM-043

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

December 27, 2018

Primary Completion Date

December 6, 2021

Study Completion Date

December 6, 2021

Conditions
Alpha-1 Antitrypsin Deficiency
Interventions
GENETIC

No Intervention

Subjects who received ADVM-043 in a parent study (ADVANCE; NCT02168686)

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

32610

University of Florida, Gainesville

Sponsors
All Listed Sponsors
lead

Adverum Biotechnologies, Inc.

INDUSTRY